R

Rafael Holdings
D

RFL

1.94000
USD
0.03
(1.57%)
مغلق
حجم التداول
29
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
47,659,332
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ADI
    -12.280
    (-5.31%)
    219.020 USD
    AVGO
    -13.820
    (-8.59%)
    147.060 USD
    INTC
    -1.620
    (-5.27%)
    29.120 USD
    MCHP
    -4.260
    (-4.80%)
    84.560 USD
    MU
    -8.340
    (-7.59%)
    101.470 USD
    NXPI
    -19.480
    (-7.40%)
    243.690 USD
    O
    ON
    -6.440
    (-8.22%)
    71.900 USD
    S
    SWKS
    -5.550
    (-4.88%)
    108.120 USD
    TXN
    -10.450
    (-5.13%)
    193.360 USD
    المزيد
الأخبار
المقالات

العنوان: Rafael Holdings

القطاع: Real Estate
الصناعة: Real Estate Services
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.